Showing results 1 to 21 of 21
Issue Date | Title | Author(s) |
---|---|---|
2022-06 | A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations | Kim, Seong A.; Kim, Seohyun; Kim, Gi Beom; Goo, Jiyoung; Kim, Nayeon; Lee, Yeram; Nam, Gi-Hoon; Lim, Seungho; Kim, Taeerk; Chang, Ki Hwan; Lee, Tae Gyu; Kim, In-San; Lee, Eun Jung |
2019-07 | An optimized protocol to determine the engulfment of cancer cells by phagocytes using flow cytometry and fluorescence microscopy | Nam, Gi-Hoon; Hong, Yeonsun; Choi, Yoonjeong; Kim, Gi Beom; Kim, Yoon Kyoung; Yang, Yoosoo; Kim, In-San |
2019-03 | Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer | Kim, In-San; Hong, Yeonsun; Nam, Gi-Hoon; Kim, Gi Beom |
2018-01-10 | Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis | Kim, Manse; Sahu, Abhishek; Kim, Gi Beom; Nam, Gi Hoon; Um, Wooram; Shin, So Jin; Jeong, Yong Yeon; Kim, In-San; Kim, Kwangmeyung; Kwon, Ick Chan; Tae, Giyoong |
2019-12 | Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103(+) dendritic cells and in combination with PD-L1 blockade boosts anti-tumour immunity | Hong, Yeonsun; Kim, Yoon Kyoung; Kim, Gi Beom; Nam, Gi-Noon; Kim, Seong A.; Park, Yoon; Yang, Yoosoo; Kim, In-San |
2020-03 | Dendritic cell activation by an E. coli-derived monophosphoryl lipid A enhances the efficacy of PD-1 blockade | Jeong, Youngmin; Kim, Gi Beom; Ji, Yuhyun; Kwak, Gi-Jung; Nam, Gi-Hoon; Hong, Yeonsun; Kim, Seohyun; An, Jinsu; Kim, Sun Hwa; Yang, Yoosoo; Chung, Hak Suk; Kim, In-San |
2021-05-10 | Design of PD-1-decorated nanocages targeting tumor-draining lymph node for promoting T cell activation | Kim, Gi Beom; Sung, Hyo-Dong; Nam, Gi-Hoon; Kim, Wonjun; Kim, Seohyun; Kang, Dayeon; Lee, Eun Jung; Kim, In-San |
2020-12 | Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy | Nam, Gi-Hoon; Choi, Yoonjeong; Kim, Gi Beom; Kim, Seohyun; Kim, Seong A.; Kim, In-San |
2018-04 | Exosome as a vehicle for delivery of membrane protein therapeutics, PH20 for enhanced tumor penetration and anti-tumor efficacy | Yang, Yoosoo; Hong, Yeonsun; Kim, In-san; Nam, Gihoon; Kim, Gi Beom |
2018-01-31 | Exosome as a Vehicle for Delivery of Membrane Protein Therapeutics, PH20, for Enhanced Tumor Penetration and Antitumor Efficacy | Hong, Yeonsun; Nam, Gi-Hoon; Koh, Eunee; Jeon, Sangmin; Kim, Gi Beom; Jeong, Cherlhyun; Kim, Dong-Hwee; Yang, Yoosoo; Kim, In-San |
2018-03 | Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery | Yang, Yoosoo; Hong, Yeonsun; Cho, Eunji; Kim, Gi Beom; Kim, In-San |
2023-09 | Harnessing Oncolytic Extracellular Vesicles for Tumor Cell-Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy | Kim, Gi Beom; Kim, Seonghyun; Hwang, Yeong Ha; Kim, Seohyun; Lee, Inkyu; Kim, Seong A.; Goo, Jiyoung; Yang, Yoosoo; Jeong, Cherlhyun; Nam, Gi-Hoon; Kim, In-San |
2021-01 | In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis | Kim, Seohyun; Kim, Seong A.; Nam, Gi-Hoon; Hong, Yeonsun; Kim, Gi Beom; Choi, Yoonjeong; Lee, Seokyoung; Cho, Yuri; Kwon, Minsu; Jeong, Cherlhyun; Kim, Sehoon; Kim, In-San |
2019-11 | Intrinsic cancer vaccination | Yang, Yoosoo; Nam, Gi-Hoon; Kim, Gi Beom; Kim, Yoon Kyoung; Kim, In-San |
2018-07 | Nanocage-therapeutics prevailing phagocytosis and immunogenic cell death awakens immunity against cancer | Nam, Gihoon; Kim, In-San; Kim, Gi Beom |
2021-09 | Nanocages displaying SIRP gamma clusters combined with prophagocytic stimulus of phagocytes potentiate anti-tumor immunity | Choi, Yoonjeong; Nam, Gi-Hoon; Kim, Gi Beom; Kim, Seohyun; Kim, Yoon Kyoung; Kim, Seong A.; Kim, Ha-Jeong; Lee, Eun Jung; Kim, In-San |
2021-03-10 | Overcoming therapeutic efficiency limitations against TRAIL-resistant tumors using re-sensitizing agent-loaded trimeric TRAIL-presenting nanocages | Je, Hyeonwoo; Nam, Gi-Hoon; Kim, Gi Beom; Kim, Wonjun; Kim, Soo Rin; Kim, In-San; Lee, Eun Jung |
2023-01 | Protein-based nanocages for vaccine development | Kim, Seong A.; Lee, Yeram; Ko, Yeju; Kim, Seohyun; Kim, Gi Beom; Lee, Na Kyeong; Ahn, Wonkyung; Kim, Nayeon; Nam, Gi-Hoon; Lee, Eun Jung; Kim, In-San |
2021-07 | Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer | Nam, Gi-Hoon; Kwon, Minsu; Jung, Hanul; Ko, Eunbyeol; Kim, Seong A.; Choi, Yoonjeong; Song, Su Jeong; Kim, Seohyun; Lee, Yeji; Kim, Gi Beom; Han, Jihoon; Woo, Jiwan; Cho, Yakdol; Jeong, Cherlhyun; Park, Seung-Yoon; Roberts, Thomas M.; Cho, Yong Beom; Kim, In-San |
2020-01 | Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E-/- mice | Kim, Manse; Sahu, Abhishek; Hwang, Youngmin; Kim, Gi Beom; Nam, Gi Hoon; Kim, In-San; Kwon, Ick Chan; Tae, Giyoong |
2020-07 | Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity | Kim, Gi Beom; Nam, Gi-Hoon; Hong, Yeonsun; Woo, Jiwan; Cho, Yakdol; Kwon, Ick Chan; Yang, Yoosoo; Kim, In-San |